Antigen presentation, the key step in the cancer immunity cycle (37), starts by capturing and processing new tumor antigens, and then presents tumor antigens bound with MHC peptides to T cells, initiating the effector T cell response against tumor-specific antigens (Figure 4A above) (54). This evidence concerns the gene HLA-C and neoplasm.